|
Volumn 365, Issue 18, 2011, Pages 1746-
|
Bardoxolone methyl, chronic kidney disease, and type 2 diabetes [4]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BARDOXOLONE METHYL;
ANTIOXIDANT;
DRUG DERIVATIVE;
OLEANOLIC ACID;
ALBUMINURIA;
CHRONIC KIDNEY DISEASE;
DIABETIC NEPHROPATHY;
DRUG EFFICACY;
GLOMERULUS FILTRATION RATE;
HUMAN;
INCIDENCE;
KIDNEY FAILURE;
LETTER;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
UNSPECIFIED SIDE EFFECT;
CHRONIC KIDNEY FAILURE;
DRUG EFFECT;
FEMALE;
MALE;
NOTE;
PATHOPHYSIOLOGY;
ANTIOXIDANTS;
DIABETES MELLITUS, TYPE 2;
FEMALE;
GLOMERULAR FILTRATION RATE;
HUMANS;
MALE;
OLEANOLIC ACID;
RENAL INSUFFICIENCY, CHRONIC;
|
EID: 80455173513
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (18)
|
References (0)
|